|
AU579148B2
(en)
|
1984-03-09 |
1988-11-17 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis b virus vaccine including both t cell and b cell determinants
|
|
US4599231A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4886782A
(en)
|
1987-02-26 |
1989-12-12 |
The United States Of America As Represented By The Department Of Health And Human Services |
Malarial immunogen
|
|
US5433948A
(en)
|
1990-02-13 |
1995-07-18 |
Thomas; Wayne R. |
Cloning and sequencing of allergens of dermatophagoides (house dust mite)
|
|
FI931393A0
(fi)
|
1990-09-27 |
1993-03-26 |
Syntello Vaccine Dev Kb |
Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus
|
|
DE69233772D1
(de)
|
1991-10-16 |
2009-11-12 |
Merck Patent Gmbh |
T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
|
|
US7252829B1
(en)
|
1998-06-17 |
2007-08-07 |
Idm Pharma, Inc. |
HLA binding peptides and their uses
|
|
US5589582A
(en)
|
1992-10-27 |
1996-12-31 |
Biotransplant, Inc. |
Polynucleotides en coding porcine cytokines
|
|
US5633234A
(en)
|
1993-01-22 |
1997-05-27 |
The Johns Hopkins University |
Lysosomal targeting of immunogens
|
|
US5824315A
(en)
|
1993-10-25 |
1998-10-20 |
Anergen, Inc. |
Binding affinity of antigenic peptides for MHC molecules
|
|
US8791237B2
(en)
|
1994-11-08 |
2014-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of non-hodgkins lymphoma
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US6399383B1
(en)
|
1997-10-28 |
2002-06-04 |
Maxygen, Inc. |
Human papilloma virus vectors
|
|
NO315238B1
(no)
|
1998-05-08 |
2003-08-04 |
Gemvax As |
Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
|
|
AR020102A1
(es)
|
1998-07-30 |
2002-04-10 |
Ucb Sa |
Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
|
|
US20030152581A1
(en)
|
1998-07-30 |
2003-08-14 |
Jean-Marie Saint-Remy |
Compound and method for the prevention and/or the treatment of allergy
|
|
US6656471B1
(en)
|
1998-11-17 |
2003-12-02 |
Board Of Regents, The University Of Texas System |
HIV-specific T-cell induction
|
|
GB0006437D0
(en)
|
2000-03-17 |
2000-05-10 |
Leuven Res & Dev Vzw |
Compounds for the modulation of allergen sensitivity by antigens sharing T cell epitopes with allergens
|
|
EP1280817A2
(en)
|
2000-04-28 |
2003-02-05 |
Novozymes A/S |
Production and use of protein variants having modified immunogenecity
|
|
EP1294905A1
(en)
|
2000-06-26 |
2003-03-26 |
SmithKline Beecham Biologics SA |
Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
|
|
US7049413B2
(en)
|
2001-05-18 |
2006-05-23 |
Ludwig Institute For Cancer Research |
MAGE-A3 peptides presented by HLA class II molecules
|
|
JP2004527263A
(ja)
|
2001-05-30 |
2004-09-09 |
フォンダツィオーネ テレソン |
免疫抑制活性を有するエクスビボ単離ｃｄ２５＋ｃｄ４＋ｔ細胞とその使用
|
|
DE60231417D1
(de)
|
2001-10-03 |
2009-04-16 |
Unilever Nv |
Kohlenhydratbindungsdomäne enthaltende fusionsproteine zur verabreichung von therapeutischen und anderen stoffen und zusammensetzungen in denen die fusionsproteine enthalten sind
|
|
US20100183652A1
(en)
|
2002-02-21 |
2010-07-22 |
Mark Page |
STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS
|
|
WO2003072731A2
(en)
|
2002-02-21 |
2003-09-04 |
Apovia, Inc. |
STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS
|
|
TW200413406A
(en)
|
2002-08-26 |
2004-08-01 |
Kirin Brewery |
Peptides and drugs containing the same
|
|
DE60327786D1
(de)
|
2002-09-12 |
2009-07-09 |
Oncotherapy Science Inc |
Kdr-peptide und diese enthaltende impfstoffe
|
|
CA2499123A1
(en)
*
|
2002-09-17 |
2004-04-15 |
Antigen Express, Inc. |
Ii-key/antigenic epitope hybrid peptide vaccines
|
|
JP2004147649A
(ja)
|
2002-10-11 |
2004-05-27 |
Kumamoto Technology & Industry Foundation |
頭頚部癌の抗原
|
|
US20070054262A1
(en)
|
2003-03-28 |
2007-03-08 |
Baker Denise M |
Methods of identifying optimal variants of peptide epitopes
|
|
US7651855B2
(en)
|
2003-04-17 |
2010-01-26 |
The Trustees Of The University Of Pennsylvania |
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses
|
|
GB0324265D0
(en)
|
2003-10-16 |
2003-11-19 |
Medical Res Council |
Peptide
|
|
US20070184023A1
(en)
|
2003-10-30 |
2007-08-09 |
Pharmexa A/S |
Method for down-regulation of vegf
|
|
JP2008044848A
(ja)
|
2004-11-30 |
2008-02-28 |
Univ Kurume |
Ｈｌａ−ａ２４拘束性腫瘍抗原ペプチド
|
|
US8252893B2
(en)
|
2005-01-31 |
2012-08-28 |
Board Of Trustees Of The University Of Arkansas |
CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
|
|
US10183986B2
(en)
|
2005-12-15 |
2019-01-22 |
Industrial Technology Research Institute |
Trimeric collagen scaffold antibodies
|
|
GB0603081D0
(en)
|
2006-02-15 |
2006-03-29 |
Dynal Biotech Asa Oslo |
Method
|
|
FR2898275B1
(fr)
|
2006-03-10 |
2012-12-14 |
Genethon |
Cellules t regulatrices cd4+cd25+specifiques pour la greffe de cellules hematopoietiques et la tolerance immunitaire
|
|
WO2007135684A2
(en)
|
2006-05-22 |
2007-11-29 |
Hadasit Medical Research Services & Development Limited |
Method of treatment of anti-cd4 autoimmunity
|
|
ES2709176T3
(es)
|
2006-08-11 |
2019-04-15 |
Life Sciences Res Partners Vzw |
Péptidos inmunogénicos y su uso en trastornos inmunitarios
|
|
ES2602610T3
(es)
|
2007-05-31 |
2017-02-21 |
Medigene Ag |
Proteína estructural mutada de un parvovirus
|
|
CA2700618A1
(en)
|
2007-09-27 |
2009-04-02 |
The Board Of Trustees Of The University Of Arkansas |
Inhibition of dendritic cell-driven regulatory t cell activation and potentiation of tumor antigen-specific t cell responses by interleukin-15 and map kinase inhibitor
|
|
EP2245059B1
(en)
|
2008-02-14 |
2017-09-20 |
Life Sciences Research Partners VZW |
Cd4+ t-cells with cytolytic properties
|
|
EP2252329B1
(en)
|
2008-02-14 |
2015-06-17 |
Life Sciences Research Partners VZW |
Elimination of immune responses to viral vectors
|
|
ES2637812T3
(es)
|
2008-02-14 |
2017-10-17 |
Life Sciences Research Partners Vzw |
Inmunoterapia dirigida a patógenos intracelulares
|
|
EP2626081B1
(en)
|
2008-02-14 |
2017-03-22 |
Life Sciences Research Partners VZW |
Immunogenic control of tumours and tumour cells
|
|
ES2584430T3
(es)
|
2008-02-14 |
2016-09-27 |
Life Sciences Research Partners Vzw |
Estrategias para prevenir y/o tratar las respuestas inmunitarias a los alofactores solubles
|
|
US9248171B2
(en)
|
2008-02-14 |
2016-02-02 |
Imcyse Sa |
Immunogenic peptides and their use in transplantation
|
|
EP2254592B1
(en)
|
2008-02-28 |
2019-06-05 |
Dako Denmark A/S |
Mhc multimers in borrelia diagnostics and disease
|
|
KR101022649B1
(ko)
|
2008-08-07 |
2011-03-22 |
삼성모바일디스플레이주식회사 |
헤테로고리 화합물 및 이를 이용한 유기 전계 발광 장치
|
|
EP2337795A2
(en)
|
2008-10-01 |
2011-06-29 |
Dako Denmark A/S |
Mhc multimers in cancer vaccines and immune monitoring
|
|
US8647879B2
(en)
*
|
2009-08-14 |
2014-02-11 |
Polytechnic Institute Of Nyu |
Peptide probe for rapid and specific detection of β-amyloid aggregation
|
|
EP3156068B1
(en)
|
2010-03-29 |
2021-11-03 |
CNRS (Centre National de la Recherche Scientifique) |
Pharmaceutical compositions comprising a polypeptide comprising at least one cxxc motif and heterologous antigens and uses thereof
|
|
WO2013121296A1
(en)
|
2012-02-15 |
2013-08-22 |
Ecole Polytechnique Federale De Lausanne |
Erythrocyte-binding therapeutics
|
|
RU2603075C2
(ru)
*
|
2010-11-25 |
2016-11-20 |
Имнейт Сарл |
Изменение иммуногенности антигена путем введения эпитопов, узнаваемых nkt-клетками
|
|
DE11787873T1
(de)
|
2010-11-25 |
2013-12-12 |
Imnate Sarl |
Immugene Peptide zur Verwendung bei der Vorbeugung und/oder Behandlung von Infektionskrankheiten, Autoimmunerkrankungen, Immunreaktionen auf Allofaktoren, allergischen Erkrankungen, Tumoren, Transplantatabstossungen und Immunreaktionen auf virale Vektoren
|
|
GB201201511D0
(en)
|
2012-01-30 |
2012-03-14 |
Univ Leuven Kath |
Modified epitopes for boosting CD4+ T-cell responses
|
|
JP2015518376A
(ja)
*
|
2012-04-30 |
2015-07-02 |
イムシス・ソシエテ・アノニムＩｍｃｙｓｅ Ｓａ |
抗原特異的な調節性ｔ細胞を誘導するための方法
|
|
US9603948B2
(en)
*
|
2012-10-11 |
2017-03-28 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
|
GB201309469D0
(en)
|
2013-05-28 |
2013-07-10 |
Imcyse Sa |
Detection of CD4+ T lymphocytes
|
|
GB201319160D0
(en)
*
|
2013-10-30 |
2013-12-11 |
Imcyse Sa |
Methods for induction of antigen-specific regulatory t cells
|
|
GB201418433D0
(en)
*
|
2014-10-17 |
2014-12-03 |
Imcyse Sa |
Novel immunogenic peptides
|
|
US10729791B2
(en)
|
2015-05-18 |
2020-08-04 |
Imcyse Sa |
Animal models for evaluating pharmaceutical compounds
|
|
CA2995771A1
(en)
|
2015-09-25 |
2017-03-30 |
Imcyse Sa |
Improved methods and compounds for eliminating immune responses to therapeutic agents
|